Onkologie (Czech Republic)

About Onkologie (Czech Republic)

Onkologie (Czech Republic) — Full Profile

Onkologie is a Czech clinical oncology journal published in the Czech Republic by Solen s.r.o., written chiefly for doctors and other health professionals who treat cancer patients in everyday practice. It is a practice journal in the full sense of that term: its issues are built around a main theme, review articles that bring a fast-moving treatment area up to date, case material shared from practice, interdisciplinary reviews, and a section for nurses. The official site, onkologiecs.cz, was showing its 2026 volume — volume 20, issue 4 — when this profile was researched, which makes the journal a long-running fixture of Czech medical publishing rather than a recent launch. This profile is anchored to the Journals World record that carries ISSN 1802-4475 and 1803-5345, and every fact below is attributed to the publisher's own site, to OpenAlex data resolved through its ISSN endpoint, or to the directory record itself.

The name needs disambiguation before anything else, because Onkologie is simply the word for oncology in Czech and German, and several unrelated journals bear it. The journal profiled here is the Czech Solen title with the ISSN pair above, DOI registrations in the 10.36290/xon series visible on its articles, and an archive on onkologiecs.cz. It is not Springer's German Die Onkologie, which carries different ISSNs (2731-7226 and 2731-7234) and has its own Journals World record and deep profile under the plain title Onkologie. It is not the older Swiss Karger journal of the same name, and it is not Klinická onkologie, the separate journal of the Czech and Slovak oncology societies. Anyone verifying this title should verify the ISSN pair and the Solen publisher together; the title alone identifies nothing.

Quick Facts

A Practice Journal for Czech Oncology

Solen is a Czech medical publisher whose journal family is organised around clinical practice — its stable includes titles for dermatology, neurology, paediatrics, psychiatry, urology, pharmacy and general practice, each with the words pro praxi, for practice, either in its title or in its positioning. Onkologie is the oncology member of that family, and its contents follow the family pattern adapted to a specialty where the evidence base changes unusually fast. A typical recent issue, as presented on the publisher's current issue page, opens with an editorial, develops a main theme — a recent example being the management of the axilla in breast cancer — and continues with review articles, material shared from practice, content for nurses, and interdisciplinary reviews. A forthcoming issue preview on the same site lists induction immunotherapy in head and neck cancer examined from the points of view of the oncologist, the pathologist and the surgeon, together with reviews on anticoagulation in cancer patients and on topics at the boundary between oncology and nursing care.

That structure tells a prospective author, and a prospective reader, a great deal. This is not a journal whose primary function is to publish original trial results for an international research audience; large trials appear here as subjects of review, interpretation and Czech clinical commentary. Its function is translation in the broad sense: taking international evidence, guideline changes such as a new staging system, and new drug classes such as checkpoint inhibitors and antibody-drug conjugates, and turning them into guidance that a Czech oncologist, or a colleague in a related specialty, can apply in a Czech clinic, under Czech reimbursement and organisational conditions, in the Czech language. Original case material earns its place when it teaches — a rare presentation, an unexpected complication, a long control of disease after a particular sequence of treatment — rather than when it merely reports.

History and Continuity, as the Archive Shows It

The publisher's archive is the most reliable public witness to the journal's continuity. It lists complete volumes year by year up to volume 20 in 2026, with four to six numbered issues in the recent years and occasional supplements, including monographic supplements such as the 2022 supplement on monoclonal gammopathies. Volume numbering of twenty in 2026 places volume 1 in 2007, and the publisher's author index independently shows citations from 2007, volume 1, which is consistent with that arithmetic. The old Journals World template described publication coverage as beginning later than that; where a template summary and the publisher's own archive differ, the archive governs, and this profile follows the archive. The same index shows the journal publishing continuously across the whole period in between — through the years when systemic treatment was dominated by chemotherapy and the first targeted agents, into the present period in which immunotherapy, molecular classification and treatment de-escalation dominate its themes.

Continuity matters for a practice journal in a way it does not for a journal of record. Clinicians build habits around a journal that arrives regularly, in their language, with a predictable mix of update and case discussion, and a run approaching two decades means several generations of Czech oncology trainees have used it that way. It also means the archive has become a Czech-language reference layer in its own right: a reader who wants to know how a treatment question was understood in Czech practice five or ten years ago will often find a review here that states it in the terms in which it was actually debated locally.

Content Anatomy: Themes, Reviews, Cases and Nursing

The sections named on the publisher's pages deserve reading as an editorial policy in miniature. The main theme gives each issue a centre of gravity, usually a disease site or a treatment problem, examined from more than one professional angle. Review articles do the updating work — new treatment approaches in a named cancer, screening questions, the place of a drug class in a treatment sequence — and they typically carry an English title and summary alongside the Czech text, as the publisher's article pages show, which makes Czech clinical scholarship at least partly discoverable to readers who do not read Czech. Material shared from practice carries the case reports and small clinical experiences. The section for nurses is a distinguishing feature: oncology nursing, symptom burden, and the experience of illness and loss appear as subjects in their own right, not as an afterthought, which reflects how much of modern cancer care is delivered and witnessed by nursing staff. Interdisciplinary reviews acknowledge that cancer patients move between surgery, radiotherapy, internal medicine, palliative care and general practice, and that a journal read by all of those groups must sometimes address them together.

OpenAlex topic data for this source, attributed in the metrics section, are consistent with that editorial shape: its largest clusters concern cancer immunotherapy and biomarkers, lung cancer treatment, colorectal cancer, and breast cancer treatment — precisely the high-incidence, fast-changing areas in which a practising oncologist most needs regular updating.

Publishing Model, Access and Identifiers

The publisher's site presents the journal as a subscription title — its navigation offers subscription arrangements for the coming year — alongside a public web archive in which article pages and PDFs are presented on the journal's own site, as the publisher's pages fetched for this profile show. OpenAlex classifies the source as not fully open access while still recording a large share of its indexed works as openly reachable, which matches that mixed picture of a print subscription journal with substantial web availability. A formal open licence statement for articles could not be verified from a source fetched for this profile, so no licence is claimed here, and any reader who needs to reuse material beyond ordinary reading should check the statement on the article itself or ask the publisher. Equally, article charges, if any, are not published in any source fetched for this profile, and authors should not assume either that a fee exists or that none does; the author instructions on the publisher's site are the place to confirm the current position before submitting.

On professional audience: the publisher's site carries a notice that its pages are intended for professionals authorised to prescribe or dispense medicines under Czech law, and are not intended for the general public, because they contain expert information about medicinal products including advertising material. Patients who reach this journal while researching their own condition should read it with that notice in mind — it is written by clinicians for clinicians, assumes clinical training, and is not a substitute for advice from their own treatment team.

Articles carry DOIs in the 10.36290/xon series, as published examples on the publisher's site show, and citations take the compact Czech form of journal, year, volume, issue and pages; a 2026 citation therefore reads in the pattern Onkologie. 2026;20(4) followed by the page. Citing the ISSN pair alongside the title in any catalogue or reference list is the reliable way to keep this journal distinct from the other titles that share its name.

Peer Review and Editorial Handling

The publisher's site footer states that its pages are served by the Actavia editorial and review system, which is the platform through which manuscripts are handled and reviewed across the Solen journal family, and the journal's own navigation provides instructions for authors and a submission route. The specific review model for this title — how many reviewers are used, and whether review is anonymous in one or both directions — could not be verified from a source fetched for this profile, so it is not stated here as fact. Authors should read the current author instructions on onkologiecs.cz for the requirements that will actually be applied to their manuscript, including format, declarations and any statements the publisher requires, and should treat this profile's silence on those points as a prompt to check, not as evidence about them.

Metrics and Indexing — Attributed, and With Limits Stated

OpenAlex, resolved through both ISSN endpoints to the single source S30203629, lists 623 works and 227 citations for this journal, with summary statistics of an h-index of 4, an i10-index of 1 and a two-year mean citedness of about 0.07, at the time the record was fetched. The h-index of 4 agrees with the figure carried in the old Journals World template, which is a small point of consistency between two independent presentations of the record. OpenAlex year counts show a substantial annual output — dozens of works per year across 2016 to 2026, including more than sixty in several recent years — which fits a practice journal publishing several issues a year with many short clinical contributions. OpenAlex also records the host organisation as Solen s.r.o. and the country as the Czech Republic, both matching the publisher's own presentation.

Those numbers should be interpreted in the journal's own terms. Citation counts for a national-language clinical practice journal will always be low beside an international research journal, because its readers use it to change what they do on Monday morning rather than to build reference lists, and much of its influence therefore never becomes a citation at all. A DOAJ listing for this title could not be verified from the DOAJ search output obtained for this profile, and no DOAJ claim is made either way; directory searches can lag and can miss, so that sentence records a limit of this research, not a finding about the journal. Likewise, no Scopus quartile, CiteScore or Journal Impact Factor is stated here, because none could be verified from a source fetched for this profile. Anyone who needs such a figure for an institutional evaluation should look the ISSNs up in the relevant official list directly and cite that lookup with its date.

Who Should Submit — and What Belongs Here

The journal's natural authors are Czech and Slovak clinicians — the two languages and medical communities are closely connected, and the wider Solen family publishes for both — who have something practice-changing or practice-clarifying to share: an up-to-date review of a treatment area written for colleagues outside the subspecialty, a case or compact case series with a clear lesson, an interdisciplinary account of a pathway that several specialties share, or a contribution on the nursing and supportive dimensions of cancer care. Manuscripts should be written for a reader who is expert in medicine but not necessarily in the author's narrow corner of oncology, should state early what changes in practice because of the article, and should engage honestly with the Czech setting — availability, guidelines and organisation — where that setting affects the recommendation.

Manuscripts that belong elsewhere are equally recognisable. A report of a major original trial aimed at the international research community will reach its intended audience through an international research journal, and a highly technical laboratory study with no clinical translation will struggle to find readers here. Authors outside the Czech system should also weigh language: this is a Czech-language journal for a Czech professional readership, and that is a strength for its purpose, but it means an English-only manuscript with no Czech clinical connection is unlikely to fit its programme. Checking the current author instructions, the recent archive and a recent main-theme issue, in that order, is the fastest reliable test of fit.

How the Journal Fits the Czech Medical Journal Landscape

Czech clinical medicine is served by a layered journal landscape. Society journals carry the official positions and guidelines-adjacent scholarship of their specialist societies, university and institute journals carry original research, and the Solen practice family, to which this title belongs, carries the continuing education layer in which most practising clinicians actually maintain their knowledge between congresses. Understanding that layer explains editorial choices that can puzzle an outside reader: why a review is preferred over a small original study, why a main theme returns to breast, lung or colorectal cancer so regularly, and why content for nurses sits inside a doctors' journal. Each choice follows from the readership's working week. Cancer is common, its treatment changes every year, its care is delivered by teams, and a journal that helps those teams keep current, in their own language and under their own system's rules, performs a service that an international research journal, however prestigious, does not perform for them at all.

For librarians and evaluators, the practical consequence is that this title should be catalogued, and judged, as a national clinical practice journal: by the regularity and completeness of its archive, the currency of its reviews, and its reach into its professional readership, rather than by international citation indicators designed for research journals. Its approaching twenty volumes, its DOI-registered articles, and its publisher's established journal family are the relevant credentials, and they are all verifiable on the publisher's own site.

Frequently Asked Questions

Is this the same journal as the German Onkologie? No. This profile covers the Czech journal published by Solen s.r.o. with ISSNs 1802-4475 and 1803-5345. Springer's Die Onkologie carries different ISSNs and its own Journals World record, and the older Swiss journal of the same name is a third, separate title. Always verify by ISSN and publisher.

Who publishes Onkologie and where can it be read? Solen s.r.o. publishes it in the Czech Republic. Its official site is onkologiecs.cz, which carries the current issue, the archive and subscription information.

How often does it appear? The publisher's archive shows four to six numbered issues per year in recent volumes, plus occasional supplements, with volume 20 appearing in 2026.

Is it open access, and what does it cost to publish? A formal open licence and any article charges could not be verified from the sources fetched for this profile, and are not claimed here. Check the article itself and the current author instructions on the publisher's site.

What are its citation metrics? OpenAlex lists 623 works, 227 citations and an h-index of 4 for source S30203629 at fetch date. No verified quartile or impact factor is claimed in this profile.

Is it the same as Klinická onkologie? No. That is a separate journal associated with the Czech and Slovak oncology societies. The similarity of names causes real confusion, and the ISSN pair is again the reliable distinction.

Sources: the publisher's official site onkologiecs.cz (home, current issue, archive and author index pages, fetched for this profile); OpenAlex source S30203629 resolved through both ISSN endpoints; DOAJ search API output for both ISSNs, treated as a verification limit as explained above. Facts were correct as fetched; editorial and subscription details can change and should be rechecked on the publisher's site.